[go: up one dir, main page]

BRPI0502080A - processo de obtenção de soro equino anti-laquético - Google Patents

processo de obtenção de soro equino anti-laquético

Info

Publication number
BRPI0502080A
BRPI0502080A BRPI0502080A BRPI0502080A BR PI0502080 A BRPI0502080 A BR PI0502080A BR PI0502080 A BRPI0502080 A BR PI0502080A BR PI0502080 A BRPI0502080 A BR PI0502080A
Authority
BR
Brazil
Prior art keywords
laqueal
obtaining anti
equine serum
obtaining
equine
Prior art date
Application number
Other languages
English (en)
Inventor
Marco Antonio Stephano
Hisako Gondo Higashi
Rosalvo Guidolin
Jose Roberto Marcelino
Josefina Farina Morais
Ivone Kazuko Yamaguchi
Denise Vilarinho Tambourgi
Osvaldo Augusto Brazil Es Anna
Original Assignee
Fundacao Butantan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Butantan filed Critical Fundacao Butantan
Priority to BRPI0502080A priority Critical patent/BRPI0502080B8/pt
Publication of BRPI0502080A publication Critical patent/BRPI0502080A/pt
Publication of BRPI0502080B1 publication Critical patent/BRPI0502080B1/pt
Publication of BRPI0502080B8 publication Critical patent/BRPI0502080B8/pt

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PROCESSO DE OBTENçãO DE SORO EQüINO ANTI-LAQUéTICO". O qual utiliza, como antígeno, o veneno da serpente Lachesis muta depletado de uma fração supressora.
BRPI0502080A 2005-06-02 2005-06-02 processo de obtenção de soro equino anti-laquético BRPI0502080B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0502080A BRPI0502080B8 (pt) 2005-06-02 2005-06-02 processo de obtenção de soro equino anti-laquético

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0502080A BRPI0502080B8 (pt) 2005-06-02 2005-06-02 processo de obtenção de soro equino anti-laquético

Publications (3)

Publication Number Publication Date
BRPI0502080A true BRPI0502080A (pt) 2007-01-23
BRPI0502080B1 BRPI0502080B1 (pt) 2018-07-24
BRPI0502080B8 BRPI0502080B8 (pt) 2021-05-25

Family

ID=37655000

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0502080A BRPI0502080B8 (pt) 2005-06-02 2005-06-02 processo de obtenção de soro equino anti-laquético

Country Status (1)

Country Link
BR (1) BRPI0502080B8 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015058275A1 (en) 2013-10-25 2015-04-30 Cristália Produtos Químicos Farmacêuticos Ltda Polynucleotide, polypeptide with immunosuppresive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypetide with immunosuppresive activity and for preventing or treating conditions that require immunosuppresion and use of a polypeptide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015058275A1 (en) 2013-10-25 2015-04-30 Cristália Produtos Químicos Farmacêuticos Ltda Polynucleotide, polypeptide with immunosuppresive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypetide with immunosuppresive activity and for preventing or treating conditions that require immunosuppresion and use of a polypeptide
US10081660B2 (en) 2013-10-25 2018-09-25 Fundação Butantan Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide

Also Published As

Publication number Publication date
BRPI0502080B1 (pt) 2018-07-24
BRPI0502080B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
PT1969007E (pt) Composições e métodos para a produção de uma composição
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
TW200738270A (en) Method of treating depression using a TNFα antibody
IL245478B (en) Regulatory t-cell epitopes, their preparations and uses
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
MX2007002675A (es) Antagonistas anti-beta7 humanizados y usos para los mismos.
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
WO2006028936A3 (en) Heteromultimeric molecules
MX2009007146A (es) Conjugados porcion del factor ix-polimero que tienen ligadura que se puede liberar.
WO2008033408A3 (en) Methods for identifying compounds that modulate cell signaling and methods employing such compounds
EA200702643A1 (ru) Антитела, связывающие tweak
NO20063624L (no) FC region varianter
WO2008082669A3 (en) Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage
WO2009112245A9 (en) Antibody against the csf-1 r
EA200701192A1 (ru) Антагонисты toll-подобного рецептора 3, способы их получения и применение
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
MY150621A (en) Anti-epha2 antibody
EA200900767A1 (ru) Антагонистические антитела против ephb3
ATE390480T1 (de) Transplant-akzeptanz induzierende zellen monocytären ursprungs, sowie deren herstellung und verwendung
MX2010002028A (es) Metodos y composiciones para modular celulas t.
WO2007073497A3 (en) Calcium channel antagonists
TW200613256A (en) Photoactive compounds
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 39/395, A61K 39/38, A61K 35/16, A61P 39/02

Ipc: A61K 35/16 (2006.01), A61K 39/38 (2006.01), A61K 3

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/07/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 870210067953, DE 26/07/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2830 DE 01-04-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.